Glofitamab With Obinutuzumab Pre-treatment for the Treatment of Central Nervous System Lymphoma

Clinical trial NCT06922604 · SUSPENDED

Trial details

NCT number: NCT06922604
Sponsor: City of Hope Medical Center
Status: SUSPENDED
Phase: Phase 1
Study type: INTERVENTIONAL

Primary Central Nervous System Lymphoma Secondary Central Nervous System Lymphoma

Start date: 2025-07-30
Primary completion: 2029-01-02
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.